This article and associated images are based on a poster originally authored by Adam Buckle, Julia Unsicker and Iain McWilliam and presented at ELRIG Drug Discovery 2025 in affiliation with Arrayjet ...

With respect to assay development, quality assurance and, ultimately, clinical adoption, the primary subject of this review, these advantages are critical. Implicit with these advantages, TMAs enable ...

ABSTRACT: The objective of this study was to analyze the effectiveness of the physiotherapeutic approach using non-invasive mechanical ventilation (NIV) in the treatment of patients with exacerbated ...

aDepartment of Pathology and Genetics, Laboratory of Cancer Medical Science, Hokuto Hospital, Obihiro, Hokkaido, Japan bDepartment of Health Screenings, Hokuto Hospital, Obihiro, Hokkaido, Japan ...

There are two key things to know about the new Applied Biosystems™ SwiftArrayStudio™ Microarray Analyzer from Thermo Fisher Scientific, said Ravi Gupta, vice president and general manager of Thermo ...

Microchips implanted into the back of the eyes of legally blind patients have helped some of them read again, according to a new study published Monday. Out of the 32 patients with geographic atrophy ...

Geographic atrophy due to age-related macular degeneration (AMD) is the leading cause of irreversible blindness and affects more than 5 million persons worldwide. No therapies to restore vision in ...

Learning to read again Study participant Sheila Irvine, a patient at Moorfields Eye Hospital, training with the PRIMA device. (Courtesy: Moorfields Eye Hospital) A tiny wireless implant inserted under ...

A new human liver organoid microarray developed by Cincinnati Children’s and Roche recreates immune-driven liver injury in the lab. Built from patient-derived stem cells and immune cells, it ...

Researchers at Cincinnati Children's Hospital Medical Center in collaboration with Roche, have developed a next-generation human liver organoid microarray platform that could help predict which drugs ...